Literature DB >> 10478944

Release of GPI-anchored Zn2+-glycerophosphocholine cholinephosphodiesterase as an amphiphilic form from bovine brain membranes by bee venom phospholipase A2.

J Y Lee1, M R Kim, D E Sok.   

Abstract

Enzymatic release of Zn(2+)-glycerophosphocholine (GPC)cholinephosphodiesterase, as an amphiphilic form, from bovine brain membranes was examined. Of various membrane hydrolases, bee PLA2 was the most effective in the release of the GPC cholinephosphodiesterase (amphiphilic form, 63-70%) from membrane. Compared to pancreatic PLA2, bee PLA2 was more efficient in the release of GPC cholinephosphodiesterase. In pH-dependent release of GP1-anchored phosphodiesterase, there was a similar pH-release profile between PLA2-mediated release and spontaneous one, implying the involvement of membrane disruption in the PLA2 action. The PLA2-mediated release showed a limited time-dependence (until 45 min) and a limited dose dependence (up to 3 units/ml), characteristic of a receptor-type binding. An ionic binding of PLA2 to membrane may be alluded from the interfering effect of anionic phospholipids on the PLA2 action. In support of an interaction between PLA2 and membrane glycoproteins, the PLA2 action was found to be blocked by lectins, wheat germ agglutinin or concanavalin A. In combination with detergent, the PLA2-mediated release was found to be enhanced synergistically by saponin, a cholesterol-complexing agent. Meanwhile, an additive interaction between PLA2 and lysolecithin suggests that PLA2 action is independent of lysolecithin. It is suggested that the binding of PLA2 to specific sites of membranes, probably rich in GPI-anchored glycoproteins, may be related to the facilitated release of GPI-anchored proteins as amphiphilic form.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478944     DOI: 10.1023/a:1021060927738

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  27 in total

1.  Determination of phosphatidylcholine in a flow injection system using immobilized enzyme reactors.

Authors:  M Masoom; R Roberti; L Binaglia
Journal:  Anal Biochem       Date:  1990-06       Impact factor: 3.365

Review 2.  Mammalian GPI proteins: sorting, membrane residence and functions.

Authors:  O Nosjean; A Briolay; B Roux
Journal:  Biochim Biophys Acta       Date:  1997-09-08

Review 3.  The glycosyl-phosphatidylinositol anchor of membrane proteins.

Authors:  M G Low
Journal:  Biochim Biophys Acta       Date:  1989-12-06

4.  Enzymatic release of Zn2+-glycerophosphocholine cholinephosphodiesterase from brain membranes by glycosylphosphatidylinositol-specific phospholipases and its regulation.

Authors:  J Y Lee; M R Kim; D E Sok
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

5.  Hydrolysis of membrane-bound liver alkaline phosphatase by GPI-PLD requires bile salts.

Authors:  J T Deng; M F Hoylaerts; M E De Broe; V O van Hoof
Journal:  Am J Physiol       Date:  1996-10

6.  Identification of membrane dipeptidase as a major glycosyl-phosphatidylinositol-anchored protein of the pancreatic zymogen granule membrane, and evidence for its release by phospholipase A.

Authors:  N M Hooper; S Cook; J Lainé; D Lebel
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

7.  Interfacial catalysis: the mechanism of phospholipase A2.

Authors:  D L Scott; S P White; Z Otwinowski; W Yuan; M H Gelb; P B Sigler
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

8.  A spectrophotometric assay of Zn(2+)-glycerophosphorylcholine phosphocholine phosphodiesterase using p-nitrophenylphosphorylcholine.

Authors:  D E Sok; M R Kim
Journal:  Anal Biochem       Date:  1992-06       Impact factor: 3.365

9.  Purification and characterization of a high-affinity binding protein for pancreatic-type phospholipase A2.

Authors:  K Hanasaki; H Arita
Journal:  Biochim Biophys Acta       Date:  1992-08-19

10.  Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D.

Authors:  C N Metz; G Brunner; N H Choi-Muira; H Nguyen; J Gabrilove; I W Caras; N Altszuler; D B Rifkin; E L Wilson; M A Davitz
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.